RENAL DYSFUNCTION IN PATIENTS WITH SARCOIDOSIS WITH OVERWEIGHT
https://doi.org/10.24884/1561-6274-2017-21-2-41-47
Abstract
THE AIM: to investigate presence of renal dysfunction in patients with sarcoidosis with overweight. PATIENTS AND METHODS: 46 patients with sarcoidosis (without signs of primary kidney and severe cardiovascular pathology) were divided into 4 groups: 1st – with obesity and active sarcoidosis, 2nd – without obesity with active sarcoidosis, 3rd – with obesity without active sarcoidosis, 4th –without obesity and active sarcoidosis. RESULTS: Negative impacts of obesity and sarcoidosis activity on GFR were found. The lowest GFR was observed in 1st group (71±10 ml/min), significantly higher – in 2nd and 3rd groups (83±8 and 82±8 ml/min) and the highest – in 4th group (110±13 ml/min). CONCLUSION: Obesity in sarcoidosis is associated with renal dysfunction.
About the Authors
V. I. Sholomova
Lomonosov Moscow state University;
I.M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Sholomova Victoria Igorevna
Lomonosov Moscow State University, Faculty of Base Medicine, Department of Internal medicine; I.M. Sechenov First Moscow State Medical University, Faculty of Preventive Medicine, Chair of Internal, Occupational diseases and pulmonology; 3rd University Clinic, Department of pulmonology and occupational diseases.
119435, Moscow, Rossolimo str., 11/5.
E. A. Saginova
Lomonosov Moscow state University
Russian Federation
Russian Federation
Saginova Evgeniya Аndreevna Ph.D.
Facultyof Base Medicine, Department of Internal medicine.
119435, Moscow, Rossolimo str, 11/5.
A. V. Balatckii
Lomonosov Moscow state University
Russian Federation
Russian Federation
Balatskij Аleksandr Vladimirovich , Ph.D.
Research and Educational Center.
119192, Moscow, Lomonosovskij prospect, 27/10.
L. M. Samohodskaia
Lomonosov Moscow state University
Russian Federation
Russian Federation
Samokhodskaya Larisa Mikhajlovna Ph.D.
Research and Educational Center; Faculty of Base Medicine; Department of Chemistry and Molecular Medicine, Research laboratory of Genetical and Cellular technologies.
119192, Moscow, Lomonosovskij prospect, 27/10.
M. Yu. Brovko
I.M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Brovko Mikhail Yur’evich Ph.D. occupational diseases
3rd University Clinic, Department of pulmonology and occupational diseases.
119435, Moscow, Rossolimo str, 11/5.
L. Frantcuzevich
Lomonosov Moscow state University
Russian Federation
Russian Federation
Frantsuzevich Lajne
Faculty of Base Medicine, Department of Internal medicine.
119192, Moscow, Lomonosovskij prospect, 27/10.
T. N. Krasnova
Lomonosov Moscow state University;
I.M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Krasnova Tat’yana Nikolaevna Ph.D. t--> pan>
Lomonosov Moscow State University, Faculty of Base Medicine, Department of Internal medicine; I.M. Sechenov First Moscow State Medical University, Faculty of Preventive Medicine, Chair of Internal, Occupational diseases and pulmonology.
119435, Moscow, Rossolimo str., 11/5.
M. V. Lebedeva
I.M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Lebedeva Marina Valer’evna Ph.D.
Faculty of Preventive Medicine, Chair of Internal, Occupational diseases and pulmonology.
119435, Moscow, Rossolimo str., 11/5.
V. V. Kraeva
Lomonosov Moscow state University;
I.M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Mukhin Nikolaj Аlekseevich M.D., Academician of the Russian Academy of Sciences.
Lomonosov Moscow State University, Faculty of Base Medicine, Department of Internal medicine; I.M. Sechenov First Moscow State Medical University, Faculty of Preventive Medicine, Chair of Internal, Occupational diseases and pulmonology.
119435, Moscow, Rossolimo str., 11/5.
N. А. Muhin
Lomonosov Moscow state University;
I.M. Sechenov First Moscow State Medical University
Russian Federation
Lomonosov Moscow State University, Faculty of Base Medicine, Department of Internal medicine; I.M. Sechenov First Moscow State Medical University, Faculty of Preventive Medicine, Chair of Internal, Occupational diseases and pulmonology
Russian Federation
Lomonosov Moscow State University, Faculty of Base Medicine, Department of Internal medicine; I.M. Sechenov First Moscow State Medical University, Faculty of Preventive Medicine, Chair of Internal, Occupational diseases and pulmonology
References
1. . Stevens GA, Singh GM, Lu Y et al. National, regional, and global trends in adult overweight and obesity prevalences. Popul Health Metr 2012;10(1):22. doi:10.1186/1478-7954-10-22
2. . Ostchega Y, Hughes JP, Terry A et al. Abdominal obesity, body mass index, and hypertension in US adults: NHANES 20072010. Am J Hypertens 2012;25(12):1271-1278. doi:10.1038/ajh.2012.120
3. . Kopple JD. Obesity and chronic kidney disease. J Ren Nutr 2010;20(5 Suppl):29-30. doi:10.1053/j.jrn.2010.05.008
4. . Mathieu C, Teta D, Vogt B et al. Obesity: what impact on renal function? Rev Med Suisse 2006;2(55):576-578, 580-571
5. . Versini M, Jeandel PY, Rosenthal E et al. Obesity in autoimmune diseases: not a passive bystander. Autoimmun Rev 2014;13(9):981-1000. doi:10.1016/j.autrev.2014.07.001
6. . Harpsoe MC, Basit S, Andersson M et al. Body mass index and risk of autoimmune diseases: a study within the Danish National Birth Cohort. Int J Epidemiol 2014;43(3):843-855. doi:10.1093/ije/dyu045
7. . Rao DA, Dellaripa PF. Extrapulmonary manifestations of sarcoidosis. Rheum Dis Clin North Am 2013;39(2):277-297. doi:10.1016/j.rdc.2013.02.007
8. . Berliner AR, Haas M, Choi MJ. Sarcoidosis: the nephrologist’s perspective. Am J Kidney Dis 2006;48(5):856-870. doi:10.1053/j.ajkd.2006.07.022
9. . Asferg CL, Andersen UB, Linneberg A et al. Obese hypertensive men have plasma concentrations of C-reactive protein similar to that of obese normotensive men. Am J Hypertens 2014;27(10):1301-1307
10. Asferg CL, Andersen UB, Linneberg A et al. Obese hypertensive men have plasma concentrations of C-reactive protein similar to that of obese normotensive men. Am J Hypertens 2014;27(10):1301-1307. doi:10.1093/ajh/hpu029
11. Siasos G, Tousoulis D, Gialafos E et al. Association of sarcoidosis with endothelial function, arterial wall properties, and biomarkers of inflammation. Am J Hypertens 2011;24(6):647-653 doi:10.1038/ajh.2011.30
12. Галлямов МГ, Сагинова ЕA, Северова ММ и др. Значение факторов гипоксии и дисфункции эндотелия в поражении почек при ожирении. Тер арх 2013;85(6):31-37. [Galliamov MG, Saginova EA, Severova MM i dr. Znachenie faktorov gipoksii i disfunktsii ehndoteliya v porazhenii pochek pri ozhirenii. Ter arkh 2013; 6:31-37]
13. Kobak S. Sarcoidosis: a rheumatologist’s perspective. Ther Adv Musculoskelet Dis 2015;7(5):196-205. doi:10.1177/1759720X15591310
14. Moe OW. Posing the question again: does chronic uric acid nephropathy exist? J Am Soc Nephrol 2010;21(3):395-397. doi:10.1681/ASN.2008101115
15. Maalouf NM, Cameron MA, Moe OW et al. Low urine pH: a novel feature of the metabolic syndrome. Clin J Am Soc Nephrol 2007;2(5):883-888. doi:10.2215/CJN.00670207
Review
For citations:
Sholomova V.I., Saginova E.A., Balatckii A.V., Samohodskaia L.M., Brovko M.Yu., Frantcuzevich L., Krasnova T.N., Lebedeva M.V., Kraeva V.V., Muhin N.А. RENAL DYSFUNCTION IN PATIENTS WITH SARCOIDOSIS WITH OVERWEIGHT. Nephrology (Saint-Petersburg). 2017;21(2):41-47. (In Russ.) https://doi.org/10.24884/1561-6274-2017-21-2-41-47
Views:
3194
Email this article 